Larkin Mary E, Barnie Annette, Braffett Barbara H, Cleary Patricia A, Diminick Lisa, Harth Judy, Gatcomb Patricia, Golden Ellen, Lipps Janie, Lorenzi Gayle, Mahony Carol, Nathan David M
Massachusetts General Hospital Diabetes Research Center, Harvard University, Boston, MA
Mt. Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
Diabetes Care. 2014 Jul;37(7):1863-9. doi: 10.2337/dc13-2361. Epub 2014 Apr 10.
The development of periarticular thickening of skin on the hands and limited joint mobility (cheiroarthropathy) is associated with diabetes and can lead to significant disability. The objective of this study was to describe the prevalence of cheiroarthropathy in the well-characterized Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort and examine associated risk factors, microvascular complications, and the effect of former DCCT therapy (intensive [INT] vs. conventional [CONV]) on its development.
This cross-sectional analysis was performed in 1,217 participants (95% of the active cohort) in EDIC years 18/19 after an average of 24 years of follow-up. Cheiroarthropathy-defined as the presence of any one of the following: adhesive capsulitis, carpal tunnel syndrome, flexor tenosynovitis, Dupuytren's contracture, or a positive prayer sign-was assessed using a targeted medical history and standardized physical examination. A self-administered questionnaire (Disabilities of the Arm, Shoulder and Hand [DASH]) assessed functional disability.
Cheiroarthropathy was present in 66% of subjects (64% of the INT group and 68% of the CONV group; P = 0.1640) and was associated with age, sex, diabetes duration, skin intrinsic fluorescence, HbA1c, neuropathy, and retinopathy (P < 0.005 for each). DASH functional disability scores were worse among subjects with cheiroarthropathy (P < 0.0001).
Cheiroarthropathy is common in people with type 1 diabetes of long duration (∼30 years) and is related to longer duration and higher levels of glycemia. Clinicians should include cheiroarthropathy in their routine history and physical examination of patients with type 1 diabetes because it causes clinically significant functional disability.
手部关节周围皮肤增厚及关节活动受限(手部关节病)的发生与糖尿病相关,且可导致严重残疾。本研究的目的是描述在特征明确的糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC)队列中手部关节病的患病率,并检查相关危险因素、微血管并发症,以及既往DCCT治疗(强化治疗[INT]与传统治疗[CONV])对其发生的影响。
本横断面分析在EDIC研究第18/19年的1217名参与者(占活跃队列的95%)中进行,平均随访24年。手部关节病定义为存在以下任何一种情况:粘连性囊炎、腕管综合征、屈指肌腱腱鞘炎、杜普伊特伦挛缩或祈祷征阳性,通过针对性病史询问和标准化体格检查进行评估。一份自我管理问卷(手臂、肩部和手部功能障碍[DASH])评估功能残疾情况日。
66%的受试者存在手部关节病(INT组为64%,CONV组为68%;P = 0.1640),且与年龄、性别、糖尿病病程、皮肤固有荧光、糖化血红蛋白、神经病变和视网膜病变相关(每项P < 0.005)。手部关节病患者的DASH功能残疾评分更差(P < 0.0001)。
手部关节病在病程较长(约30年)的1型糖尿病患者中很常见,且与病程较长和血糖水平较高有关。临床医生应在对1型糖尿病患者进行常规病史询问和体格检查时纳入手部关节病,因为它会导致具有临床意义的功能残疾。